Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$16.10
-0.77%
Mkt Cap $2.01B
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$15.50
Range $15.00 – $16.00
Implied Upside
-3.7%
Consensus $15.50 vs current $16.10
NASDAQ·Healthcare·Biotechnology
$16.10
-0.77%
Mkt Cap $2.01B
No recent rating data.
Price Target (9 analysts)
$15.50
Range $15.00 – $16.00
-3.7%
Consensus $15.50 vs current $16.10